LIAONING CHENG DA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.94 CNY | +0.30% |
|
-1.97% | -15.62% |
| 2023 | Liaoning Cheng Da Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | Liaoning Cheng Da Co., Ltd.(XSSC:600739) added to S&P Global BMI Index | CI |
| Sales 2021 | 18.37B 2.54B | Sales 2022 | 14.56B 2.01B | Capitalization | 19.19B 2.65B |
|---|---|---|---|---|---|
| Net income 2021 | 2.16B 298M | Net income 2022 | 1.22B 169M | EV / Sales 2021 | 1.93 x |
| Net Debt 2021 | 5.57B 770M | Net Debt 2022 | 5.36B 740M | EV / Sales 2022 | 1.69 x |
| P/E ratio 2021 |
13.8
x | P/E ratio 2022 |
15.7
x | Employees | 3,406 |
| Yield 2021 |
1.13% | Yield 2022 |
1.19% | Free-Float | 56.44% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.30% | ||
| 1 week | -1.97% | ||
| Current month | -2.07% | ||
| 1 month | -6.93% | ||
| 3 months | -11.72% | ||
| 6 months | -21.11% | ||
| Current year | -15.62% |
1 week
9.73
10.31
1 month
9.7310.82
Current year
9.0312.06
1 year
9.0315.05
3 years
9.0326.65
5 years
9.0331.85
10 years
9.0337.59
| Managers | Title | Age | Since |
|---|---|---|---|
Hao Zhu
DFI | Director of Finance/CFO | 50 | 21-08-17 |
Yu Ge
PSD | President | 62 | 06-05-15 |
Shan Wei Zhang
BRD | Director/Board Member | 44 | 21-08-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shu Zhi Shang
CHM | Chairman | 72 | 06-05-15 |
Yu Ge
PSD | President | 62 | 06-05-15 |
Zhan Yang Yu
CHM | Chairman | 53 | 21-08-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.37% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 9.94 | +0.30% | 8,574,559 |
| 24-04-12 | 9.91 | -1.78% | 7,955,802 |
| 24-04-11 | 10.09 | -0.98% | 8,524,403 |
| 24-04-10 | 10.19 | -0.97% | 5,141,200 |
| 24-04-09 | 10.29 | +1.48% | 5,392,997 |
End-of-day quote Shanghai S.E., April 14, 2024
More quotes
Liaoning Chengda Co., Ltd. is a diversified group organized around six sectors of activity:
- retail distribution of clothes;
- consumer goods trading: chemical products, oils for food, textile products, electronic products, construction materials, health products, etc.;
- detention and operating of drugstores;
- development of vaccines;
- development of energetic projects: coalmines operating, production petrol, etc.;
- financial services.
Net sales are distributed geographically as follows: China (92.1%), Asia (4.9%), Americas (2.5%), Europe (0.2%), Africa (0.2%) and Oceania (0.1%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -15.62% | 2.09B | |
| +28.00% | 676B | |
| +24.27% | 559B | |
| -7.34% | 356B | |
| +15.33% | 320B | |
| +5.51% | 286B | |
| +2.62% | 213B | |
| +0.15% | 207B | |
| -9.41% | 199B | |
| -8.05% | 142B |
- Stock Market
- Equities
- 600739 Stock
